These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 9920024)
1. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures. Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown. Shingleton WD; Ellis AJ; Rowan AD; Cawston TE J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843 [TBL] [Abstract][Full Text] [Related]
4. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Kozaci LD; Buttle DJ; Hollander AP Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612 [TBL] [Abstract][Full Text] [Related]
6. Activation of cartilage matrix metalloproteinases by activated protein C. Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107 [TBL] [Abstract][Full Text] [Related]
7. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Milner JM; Elliott SF; Cawston TE Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371 [TBL] [Abstract][Full Text] [Related]
8. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Yasuda T; Poole AR Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors. Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes. Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367 [TBL] [Abstract][Full Text] [Related]
11. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
12. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178 [TBL] [Abstract][Full Text] [Related]
13. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430 [TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080 [TBL] [Abstract][Full Text] [Related]
15. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis. Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343 [TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Milner JM; Rowan AD; Cawston TE; Young DA Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164 [TBL] [Abstract][Full Text] [Related]
19. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown. Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524 [TBL] [Abstract][Full Text] [Related]
20. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Curtis CL; Rees SG; Little CB; Flannery CR; Hughes CE; Wilson C; Dent CM; Otterness IG; Harwood JL; Caterson B Arthritis Rheum; 2002 Jun; 46(6):1544-53. PubMed ID: 12115185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]